Zydus Wellness Ltd
NSE:ZYDUSWELL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 473.85
2 397.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Zydus Wellness Ltd
Zydus Wellness Ltd
Note Receivable
Zydus Wellness Ltd
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zydus Wellness Ltd
NSE:ZYDUSWELL
|
Note Receivable
₹204m
|
CAGR 3-Years
144%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-2%
|
|
|
Tata Consumer Products Ltd
NSE:TATACONSUM
|
Note Receivable
₹1.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
19%
|
CAGR 10-Years
0%
|
|
|
Britannia Industries Ltd
NSE:BRITANNIA
|
Note Receivable
₹1.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
18%
|
CAGR 10-Years
8%
|
|
|
Patanjali Foods Ltd
NSE:PATANJALI
|
Note Receivable
₹801.6m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Marico Ltd
NSE:MARICO
|
Note Receivable
₹1.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
26%
|
CAGR 10-Years
8%
|
|
|
Nestle India Ltd
NSE:NESTLEIND
|
Note Receivable
₹83.9m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-24%
|
|
Zydus Wellness Ltd
Glance View
Zydus Wellness Ltd. engages in the business of development, production, marketing, and distribution of health and wellness products. The company is headquartered in Ahmedabad, Gujarat and currently employs 1,075 full-time employees. The firm operates as an integrated consumer company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands, such as Everyuth, Nutralite, Complan, Glucon-D, Sugarlite, Everyuth, Nycil and Sugar Free D’lite. Complan is a health food drink, scientifically designed for growing school children and contains nutrients along with milk protein. Sugar Free is a low-calorie sweetener, which is a replacement of sugar for the calorie-conscious, weight watchers and diabetics. Glucon-D is a glucose powder, which is available in various flavors variants with Vitamin D and Vitamin C. Everyuth offers a range of skincare products under the brand name of Everyuth Naturals. Nycil prickly heat and cooling powder brand and has also expanded portfolio into hand sanitizer category.
See Also
What is Zydus Wellness Ltd's Note Receivable?
Note Receivable
204m
INR
Based on the financial report for Jun 30, 2024, Zydus Wellness Ltd's Note Receivable amounts to 204m INR.
What is Zydus Wellness Ltd's Note Receivable growth rate?
Note Receivable CAGR 10Y
-2%
Over the last year, the Note Receivable growth was 130%. The average annual Note Receivable growth rates for Zydus Wellness Ltd have been 144% over the past three years , -23% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
